Ethos Financial Group, LLC Northwest Biotherapeutics Inc Call Options Transaction History
Ethos Financial Group, LLC
- $568 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NWBO
# of Institutions
15Shares Held
688KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC424KShares$127,2930.03% of portfolio
-
Opus Capital Group, LLC60.2KShares$18,0450.0% of portfolio
-
Maripau Wealth Management LLC Fort Wayne, IN39.5KShares$11,8470.01% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$10,5000.0% of portfolio
-
Mai Capital Management20KShares$6,0000.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $311M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...